AR and neoplasm: An overwhelming number of publications demonstrate that the AR is a favorable prognostic marker (i.e., that the AR is a protective protein), regardless of the tumor subtype, and suggest that in most, if not all, cases AR expression is inversely proportional to tumor size, aggressiveness, pathological grade, and directly proportional to DFS, progression-free survival (PFS), and OS.